Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.

Published

Journal Article

To determine the efficacy of "short-course" therapy (less than 17 days) for Staphylococcus aureus catheter-associated bacteremia, 13 patients were prospectively followed up for at least three months after completion of therapy. A single patient relapsed after 28 days with endocarditis. No clinical or microbiological predictors of relapse could be identified, and coexistent medical conditions associated with some degree of immunosuppression did not appear to predispose to relapse. The results of this study and a review of the literature indicate that short-course therapy for uncomplicated S aureus catheter-associated bacteremia has a relapse rate of only 5% to 10% and, therefore, is reasonable therapy for this condition. The majority of relapses are endocarditis and occur within ten weeks after completion of therapy. Close follow-up during this period is essential.

Full Text

Duke Authors

Cited Authors

  • Ehni, WF; Reller, LB

Published Date

  • March 1989

Published In

Volume / Issue

  • 149 / 3

Start / End Page

  • 533 - 536

PubMed ID

  • 2919931

Pubmed Central ID

  • 2919931

International Standard Serial Number (ISSN)

  • 0003-9926

Language

  • eng

Conference Location

  • United States